Literature DB >> 12231121

Effects of butyltins on human 5alpha-reductase type 1 and type 2 activity.

Dagmar D Doering1, Stephan Steckelbroeck, Thomas Doering, Dietrich Klingmüller.   

Abstract

Butyltins are widely used biocides and accumulate in the food chain. Tributyltin is an imposex-inducing endocrine disrupter in animals. Imposex is characterized by the development of additional male sex organs on females. In a previous study, we identified tributyltin as an inhibitor of human cytochrom P450 aromatase activity. The present work focuses on the impact of butyltins on human androgen metabolism. Activation of androgens is mediated by two human 5alpha-reductase isoenzymes. 5alpha-Reductase type 1 was completely inhibited by tributyltin chloride (IC50=19.9 microM) and dibutyltin dichloride (IC50=32.9 microM), whereas 5alpha-reductase type 2 was only inhibited by tributyltin chloride (IC50=10.8 microM). Both isoenzymes were not affected by tetrabutyltin or monobutyltin indicating that at least two butyl groups bound to the positively charged Sn are required for the interaction of butyltins with the enzymes. Tributyltin inhibited 5alpha-reductase type 1 competitively whereas an irreversible inhibition was evident for the type 2 isoenzyme. In contrast to the distinct effects on 5alpha-reductases, reductive brain 17beta-hydroxysteroid dehydrogenase activity was not inhibited by any butyltin. Insufficient activation of androgens is responsible for developmental disorders of the male reproductive system such as hypospadias. At pharmacologic levels butyltins might contribute to the onset of developmental disorders of the male reproductive system. At present, however, it is unknown whether these levels are reached after acute or chronic exposure to butyltins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231121     DOI: 10.1016/s0039-128x(02)00051-x

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  6 in total

1.  Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids.

Authors:  Atanas G Atanasov; Lyubomir G Nashev; Steven Tam; Michael E Baker; Alex Odermatt
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

Review 2.  COMPRENDO: Focus and approach.

Authors:  Ulrike Schulte-Oehlmann; Triantafyllos Albanis; Axel Allera; Jean Bachmann; Pia Berntsson; Nicola Beresford; Daniela Candia Carnevali; Francesca Ciceri; Thierry Dagnac; Jerzy Falandysz; Silvana Galassi; David Hala; Gemma Janer; Roger Jeannot; Susan Jobling; Isabella King; Dietrich Klingmüller; Werner Kloas; Kresten Ole Kusk; Ramon Levada; Susan Lo; Ilka Lutz; Jörg Oehlmann; Stina Oredsson; Cinta Porte; Marian Rand-Weaver; Vasilis Sakkas; Michela Sugni; Charles Tyler; Ronny van Aerle; Christoph van Ballegoy; Leah Wollenberger
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

Review 3.  Inhibitors of testosterone biosynthetic and metabolic activation enzymes.

Authors:  Leping Ye; Zhi-Jian Su; Ren-Shan Ge
Journal:  Molecules       Date:  2011-12-02       Impact factor: 4.411

Review 4.  Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

5.  NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells.

Authors:  Shigeru Yamada; Yaichiro Kotake; Yosuke Demizu; Masaaki Kurihara; Yuko Sekino; Yasunari Kanda
Journal:  Sci Rep       Date:  2014-08-05       Impact factor: 4.379

Review 6.  Overview of the Pathophysiological Implications of Organotins on the Endocrine System.

Authors:  Vinicius Bermond Marques; Rodrigo Alves Faria; Leonardo Dos Santos
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-16       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.